Should dose-dense paclitaxel in combination with carboplatin be the new standard for treatment for suboptimally debulked patients or patients treated with neoadjuvant chemotherapy?

Marilyn Huang, Robert L. Coleman

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)51-52
Number of pages2
JournalClinical Ovarian and other Gynecologic Cancer
Issue number2
StatePublished - Dec 2012
Externally publishedYes


  • Metronomic chemo
  • Ovarian cancer

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Cite this